<table className="table">
  <caption><p>
    Treatment of Skin Infections</p>
  </caption>
  <thead>
    <tr>
      <th rowSpan="1" colSpan="1"><p>
        Infection</p>
      </th>
      <th rowSpan="1" colSpan="1"><p>
        Treatment</p>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr className="group_1-1 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Erysipelas or cellulitis<sup>
        a</sup></p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Mild: PO penicillin, cephalexin, dicloxacillin, clindamycin</p><p>
        Moderate: IV penicillin, ceftriaxone, cefazolin, clindamycin<sup>
        b</sup></p><p>
        Severe: Surgical assessment for possible necrotizing infection and empiric IV vancomycin plus piperacillin-tazobactam, imipenem, or meropenem</p>
      </td>
    </tr>
    <tr className="group_1-2 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Necrotizing fasciitis</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Polymicrobial infection: Surgical assessment/debridement and combination therapy such as vancomycin plus piperacillin-tazobactam or imipenem or meropenem</p><p><i>
        Streptococcus pyogenes</i>
        or<i>
        Clostridium</i>
        species: Surgical assessment/debridement and penicillin plus clindamycin</p><p><i>
        Aeromonas hydrophila</i>
        : Surgical assessment/debridement and ciprofloxacin or ceftriaxone plus doxycycline</p><p><i>
        Vibrio vulnificus</i>
        : Surgical assessment/debridement and third-generation cephalosporin (ceftazidime, ceftriaxone, or cefotaxime) plus doxycycline</p>
      </td>
    </tr>
    <tr className="group_1-3 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Folliculitis</p>
      </td>
      <td rowSpan="1" colSpan="1"><p><i>
        Staphylococcus aureus</i>
        : Usually self-limited; can use topical mupirocin, clindamycin, or retapamulin; systemic antibiotics usually not needed</p><p><i>
        Pseudomonas aeruginosa</i>
        (i.e., hot tub folliculitis): Usually self-limited; PO ciprofloxacin usually reserved for immunosuppressed host or for persistent or severe infection</p>
      </td>
    </tr>
    <tr className="group_1-4 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Furuncle, carbuncle, or abscess</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Mild: Incision and drainage; consider empiric PO anti-MRSA antibiotic such as trimethoprim-sulfamethoxazole or doxycycline<sup>
        c</sup></p><p>
        Moderate: Incision and drainage plus empiric PO trimethoprim-sulfamethoxazole or PO doxycycline pending culture and susceptibilities<sup>
        c</sup></p><p>
        Severe: Incision and drainage plus empiric vancomycin, daptomycin, linezolid, telavancin, or ceftaroline pending culture and susceptibilities</p>
      </td>
    </tr>
  </tbody>
</table>